Antidepressants dilate your pupils by disrupting the balance between two tiny muscles in your iris. Your pupil size is controlled by a constricting muscle (the sphincter) and a dilating muscle (the dilator), and antidepressants tip the scales toward dilation through up to three different chemical pathways depending on the type of drug. This effect is persistent for as long as you take the medication and doesn’t fade with time.
How Your Pupil Size Is Normally Controlled
Two muscles work against each other inside your iris like a tug of war. The sphincter muscle wraps around the pupil in a ring and squeezes it smaller. The dilator muscle fans outward like spokes on a wheel and pulls the pupil open. In normal conditions, signals from your nervous system keep these two muscles in balance, adjusting pupil size for light levels and focus.
The sphincter muscle constricts when it receives signals through acetylcholine, a chemical messenger in the parasympathetic (“rest and digest”) nervous system. The dilator muscle opens the pupil when it gets signals from norepinephrine and serotonin, which are part of the sympathetic (“fight or flight”) system. Antidepressants change the levels of one or more of these chemicals, and the pupil responds accordingly.
Three Pathways That Cause Dilation
Different classes of antidepressants cause pupil dilation through different mechanisms, and some hit all three at once.
Serotonin: SSRIs and SNRIs raise serotonin levels in the brain and throughout the body, including the eye. Serotonergic nerve fibers run the entire length of the dilator muscle, and when serotonin activates receptors there (specifically the 5-HT2 subtype), the dilator contracts and the pupil opens. At the same time, serotonin relaxes the sphincter muscle, reducing its ability to constrict the pupil. This is the primary route for SSRIs like fluoxetine and sertraline.
Norepinephrine: SNRIs and tricyclic antidepressants also boost norepinephrine, which directly stimulates the dilator muscle. This adds a second force pulling the pupil open on top of the serotonin effect. Venlafaxine, a common SNRI, lists mydriasis (the clinical term for dilated pupils) as a side effect occurring in about 2% of patients in clinical trials, compared to less than 1% on placebo.
Anticholinergic blocking: Tricyclic antidepressants have a third mechanism that newer drugs mostly lack. They block acetylcholine receptors on the sphincter muscle, essentially cutting the signal that tells the pupil to constrict. With the constricting muscle disabled and the dilating muscle stimulated by both serotonin and norepinephrine, tricyclics produce the most pronounced pupil dilation of any antidepressant class. This is why blurry vision is a common complaint with older tricyclics: the same blocking action that dilates the pupil also interferes with your eye’s ability to focus up close.
Which Antidepressants Cause the Most Dilation
Tricyclic antidepressants cause the most noticeable pupil dilation because they hit all three pathways simultaneously: raising serotonin, raising norepinephrine, and blocking acetylcholine. SSRIs cause milder dilation because they primarily work through just the serotonin pathway. SNRIs fall in the middle, adding norepinephrine stimulation to the serotonin effect without the strong anticholinergic component.
The formal incidence rates from clinical trials likely undercount how many people experience some degree of dilation, since mild changes in pupil size often go unnoticed. Many people only realize their pupils look different when someone else points it out or when they notice increased light sensitivity.
The Effect Doesn’t Wear Off
Unlike many antidepressant side effects that ease up as your body adjusts, pupil dilation persists for the duration of treatment. A study comparing SSRI users who had been on the medication for less than six months to those who had taken it for six months or longer found no difference: both groups had significantly larger pupils than people not taking SSRIs (averaging about 3.5 mm versus 3.1 mm in controls). Your pupils will likely return to their baseline size after you stop the medication, but they won’t adapt while you’re still on it.
In practical terms, this means you may notice more glare when driving at night or increased sensitivity to bright sunlight. Sunglasses help, and the dilation itself is harmless for the vast majority of people.
When Pupil Dilation Becomes a Concern
For most people, antidepressant-related pupil dilation is a cosmetic nuisance at worst. But for a small group, it raises a genuine medical risk. When the pupil dilates, the bunched-up iris tissue can physically block the drainage channel where fluid exits the eye. If fluid can’t drain, pressure inside the eye spikes rapidly. This is called acute angle-closure glaucoma, and it’s an emergency.
The symptoms are hard to miss: sudden severe eye pain, headache, blurred vision, nausea, and seeing halos around lights. The American Academy of Ophthalmology notes that some antidepressants, particularly escitalopram, have also been linked to fluid shifts inside the eye that push the lens and iris forward, further narrowing the drainage angle.
The people most at risk are those with naturally shallow anterior chambers in their eyes, a trait more common in people who are farsighted, women, older adults, and people of East Asian descent. For patients with known risk factors, some clinical guidelines recommend a baseline eye exam before starting an antidepressant, including pressure measurement and gonioscopy (a test that checks whether the drainage angle is open or narrow). If you’ve been told you have narrow angles or are at risk for angle-closure glaucoma, mention it before starting any antidepressant so your prescriber can factor it into the choice of medication.